Ascentage Pharma Group International (FRA:36X) EV-to-Revenue : 15.97 (As of Jun. 02, 2025)

Ascentage Pharma Group International EV-to-Revenue Chart

Ascentage Pharma Group International Annual Data
	Trend	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-Revenue		Get a 7-Day Free Trial				557.16	194.61	30.61	35.95	14.16

Ascentage Pharma Group International Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EV-to-Revenue	Get a 7-Day Free Trial											30.61	-	35.95	-	14.16

Competitive Comparison of Ascentage Pharma Group International's EV-to-Revenue

For the Biotechnology subindustry, Ascentage Pharma Group International's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascentage Pharma Group International's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascentage Pharma Group International's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Ascentage Pharma Group International's EV-to-Revenue falls into.

Ascentage Pharma Group International EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Ascentage Pharma Group International's EV-to-Revenue for today is calculated as:

Ascentage Pharma Group International's current Enterprise Value is €2,012.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ascentage Pharma Group International's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was €126.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascentage Pharma Group International  (FRA:36X) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Ascentage Pharma Group International's PS Ratiofor today is calculated as:

Ascentage Pharma Group International's share price for today is €5.55.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2024 was €0.42.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascentage Pharma Group International EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Ascentage Pharma Group International's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascentage Pharma Group International Business Description